John G. Wesseling

909 total citations
21 papers, 726 citations indexed

About

John G. Wesseling is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, John G. Wesseling has authored 21 papers receiving a total of 726 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Genetics and 7 papers in Oncology. Recurrent topics in John G. Wesseling's work include Virus-based gene therapy research (9 papers), CAR-T cell therapy research (6 papers) and Systemic Lupus Erythematosus Research (4 papers). John G. Wesseling is often cited by papers focused on Virus-based gene therapy research (9 papers), CAR-T cell therapy research (6 papers) and Systemic Lupus Erythematosus Research (4 papers). John G. Wesseling collaborates with scholars based in Netherlands, United States and Sweden. John G. Wesseling's co-authors include M.A. Smits, John G.G. Schoenmakers, Dirkjan van Schaardenburg, Cornelis L. Verweij, Saskia Vosslamber, Norbert Looije, Joyce Lübbers, Albert K. Groen, Roelof Ottenhoff and Robert A.F.M. Chamuleau and has published in prestigious journals such as Annals of Surgery, Biochemical and Biophysical Research Communications and Journal of Hepatology.

In The Last Decade

John G. Wesseling

21 papers receiving 714 citations

Peers

John G. Wesseling

GENET

IMMUN

PHEOH

RHEUM

Colleen M. Elso Australia

S Avraméas France

R. Aston United Kingdom

Tamiko Nakajima Japan

Lene Udby Denmark

Anna Zhou United States

S J Degen United States

Maria Cristina Gauzzi Italy

Linden J. Gearing Australia

E I Walter United States

Colleen M. Elso Australia

John G. Wesseling

226 ×0.8

413 ×2.8

GENET

286 ×2.0

IMMUN

173 ×1.3

PHEOH

48 ×0.4

RHEUM

Citations per year, relative to John G. Wesseling John G. Wesseling (= 1×) peers Colleen M. Elso

Countries citing papers authored by John G. Wesseling

Since Specialization

Citations

This map shows the geographic impact of John G. Wesseling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John G. Wesseling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John G. Wesseling more than expected).

Fields of papers citing papers by John G. Wesseling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John G. Wesseling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John G. Wesseling. The network helps show where John G. Wesseling may publish in the future.

Co-authorship network of co-authors of John G. Wesseling

This figure shows the co-authorship network connecting the top 25 collaborators of John G. Wesseling. A scholar is included among the top collaborators of John G. Wesseling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John G. Wesseling. John G. Wesseling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lübbers, Joyce, Marian H. van Beers-Tas, Saskia Vosslamber, et al.. (2016). Changes in peripheral blood lymphocyte subsets during arthritis development in arthralgia patients. Arthritis Research & Therapy. 18(1). 205–205. 33 indexed citations

Vosslamber, Saskia, Sander de Ridder, John G. Wesseling, et al.. (2016). Physiological evidence for diversification of IFNα- and IFNβ-mediated response programs in different autoimmune diseases. Arthritis Research & Therapy. 18(1). 49–49. 28 indexed citations

Lübbers, Joyce, Mikael Brink, Lotte A van de Stadt, et al.. (2013). The type I IFN signature as a biomarker of preclinical rheumatoid arthritis. Annals of the Rheumatic Diseases. 72(5). 776–780. 120 indexed citations

Bakker, Conny, et al.. (2009). Ephrin A2 receptor targeting does not increase adenoviral pancreatic cancer transduction in vivo. World Journal of Gastroenterology. 15(22). 2754–2754. 14 indexed citations

Kuhlmann, Koert F.D., Dirk J. Gouma, & John G. Wesseling. (2008). Adenoviral Gene Therapy for Pancreatic Cancer: Where Do We Stand?. Digestive Surgery. 25(4). 278–292. 10 indexed citations

Marsman, Willem A., et al.. (2007). Adenoviral Serotypes in Gene Therapy for Esophageal Carcinoma. Journal of Surgical Research. 140(1). 50–54. 5 indexed citations

Marsman, Willem A., Christianne J. Buskens, John G. Wesseling, J. Jan B. van Lanschot, & Piter J. Bosma. (2005). Gene therapy for barrett's esophagus: adenoviral gene transfer in different intestinal models. Cancer Gene Therapy. 12(9). 778–786. 5 indexed citations

Lie‐A‐Ling, Michael, Conny Bakker, Ruurdtje Hoekstra, et al.. (2005). Selection of tumour specific promoters for adenoviral gene therapy of cholangiocarcinoma. Journal of Hepatology. 44(1). 126–133. 12 indexed citations

Marsman, Willem A., Christianne J. Buskens, John G. Wesseling, et al.. (2004). Gene therapy for esophageal carcinoma: the use of an explant model to test adenoviral vectors ex vivo. Cancer Gene Therapy. 11(4). 289–296. 15 indexed citations

10.

Pietersen, Alexandra M, Saskia A. Rutjes, Joost van Tongeren, et al.. (2003). The tumor-selective viral protein apoptin effectively kills human biliary tract cancer cells. Journal of Molecular Medicine. 82(1). 56–63. 9 indexed citations

11.

Rutjes, Saskia A., Piter J. Bosma, Jennifer Rohn, Mathieu H. M. Noteborn, & John G. Wesseling. (2003). Induction of insolubility by herpes simplex virus VP22 precludes intercellular trafficking of N-terminal Apoptin-VP22 fusion proteins. Journal of Molecular Medicine. 81(9). 558–565. 10 indexed citations

12.

Buskens, Christianne J., Willem A. Marsman, John G. Wesseling, et al.. (2003). A Genetically Retargeted Adenoviral Vector Enhances Viral Transduction in Esophageal Carcinoma Cell Lines and Primary Cultured Esophageal Resection Specimens. Annals of Surgery. 238(6). 815–826. 12 indexed citations

13.

Schaap, Frank G., J.H.M. Levels, Roelof Ottenhoff, et al.. (2002). Adenoviral overexpression of apolipoprotein A-V reduces serum levels of triglycerides and cholesterol in mice. Biochemical and Biophysical Research Communications. 295(5). 1156–1159. 147 indexed citations

14.

Wesseling, John G., Masato Yamamoto, Yasuo Adachi, et al.. (2001). Midkine and cyclooxygenase-2 promoters are promising for adenoviral vector gene delivery of pancreatic carcinoma. Cancer Gene Therapy. 8(12). 990–996. 42 indexed citations

15.

Wesseling, John G., et al.. (1993). The γ-tubulin gene of the malaria parasite Plasmodium falciparum. Molecular and Biochemical Parasitology. 60(1). 27–35. 22 indexed citations

16.

Wesseling, John G., Ron P. Dirks, M.A. Smits, & John G.G. Schoenmakers. (1989). Nucleotide sequence and expression of a β-tubulin gene from Plasmodium falciparum, a malarial parasite of man. Gene. 83(2). 301–309. 27 indexed citations

17.

Wesseling, John G., et al.. (1989). Stage-specific expression and genomic organization of the actin genes of the malaria parasite Plasmodium falciparum. Molecular and Biochemical Parasitology. 35(2). 167–176. 86 indexed citations

18.

Wesseling, John G., et al.. (1988). Nucleotide sequence and deduced amino acid sequence of a Plasmodium falciparum actin gene. Molecular and Biochemical Parasitology. 27(2-3). 313–320. 47 indexed citations

19.

Wesseling, John G., M.A. Smits, & John G.G. Schoenmakers. (1988). Extremely diverged actin proteins in Plasmodium falciparum. Molecular and Biochemical Parasitology. 30(2). 143–153. 60 indexed citations

20.

Wesseling, John G., et al.. (1982). Maintenance of the bacteriocinogenic plasmid clo DF13 in Escherichia coli cells. Molecular and General Genetics MGG. 186(4). 531–539. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact